High dose chloroquine versus micronized halofantrine in chloroquine-resistant Plasmodium falciparum malaria.
Wildling
E
E
Department of Infectious Diseases, University of Vienna, Austria.
Jenne
L
L
Graninger
W
W
Bienzle
U
U
Kremsner
P G
PG
D000293:Adolescent; D000962:Antimalarials / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002738:Chloroquine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004351:Drug Resistance; D005260:Female; D006801:Humans; D016778:Malaria, Falciparum / Q000188:drug therapy* / Q000469:parasitology; D008297:Male; D010616:Phenanthrenes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D000962:Antimalarials; D010616:Phenanthrenes; D002738:Chloroquine; C023768:halofantrine